Avenzo Therapeutics
PrivateLast Round
Series B
9/22/2025
Total Funding Raised
$792.5M
Momentum Score
25 /100
Company Overview
Avenzo is a biotechnology company that develops innovative treatments for underserved cancers through a pipeline of oncology drug candidates targeting rare and genomically defined cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avenzo Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Avenzo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | 9/22/2025 | ||||
| Series A | 11/18/2024 | ||||
| Series A Extension | 3/26/2024 | ||||
| Series A | 5/25/2023 |
Key People
Founding team and executive leadership
Avenzo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series A Extension, Series A, Series B |
| New Enterprise Associates (NEA) | Series B, Series A |
| TF Capital | Series A Extension, Series A, Series B |
| 渶策资本 | Series A Extension, Series A, Series B |
| Deep Track Capital | Series B, Series A Extension, Series A |
| OrbiMed | Series A Extension, Series A, Series B |
| Foresite Capital | Series A Extension, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 21, 2025
Acquired ex-Greater China rights for an asset for $50M upfront.
- Oct 30, 2025
Presented at the 2025 San Antonio Breast Cancer Symposium.
Avenzo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avenzo Therapeutics's valuation, stock price, and market status.
